Health Lab
A team of hepatologists explore the effects of caffeine on liver health.
Health Lab
A liver specialist teams up with a nutrition epidemiologist to examine the direct impact of consuming sugar-sweetened beverages on developing liver disease.
Health Lab
Cirrhosis of the liver is a complex condition that requires a network of support to manage. Two U-M experts are working to improve the quality of cirrhosis prevention and care.
Health Lab
The human liver can regenerate, making living donor liver transplants possible. Michigan Medicine’s Transplant Center is one of only a few in the country offering this option.
Health Lab
The drug terlipressin is commonly used to treat hepatorenal syndrome in other parts of the world, but lacks FDA approval. Researchers examine both its efficacy and safety.
Health Lab
A team explores the protective capabilities of consuming a diet enriched with fructose when it comes to acetaminophen overdose causing liver damage in mice.
Health Lab
A team explores the possible association between human genetic variants and liver attenuation that may also indicate a new pathway for lowering triglycerides and cholesterol.
Health Lab
A hepatologist comments on the new USPSTF guidelines for detecting hepatitis B in non-pregnant adults and adolescents.
Health Lab
Basic science research explores the effects of impaired glycine metabolism in nonalcoholic fatty liver disease and how to potentially use glycine-based treatment to help people with NAFLD.
Health Lab
A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Health Lab
The rate of cirrhosis in patients with nonalcoholic fatty liver disease is lower among Americans with lower BMIs.
Health Lab
One liver transplant cured a patient of three chronic conditions: liver cancer, hepatitis C and hemophilia.
Health Lab
Michigan Medicine researchers have advanced the global fight to eliminate hepatitis C by creating a barrier-breaking reliable, low-cost and scalable test for HCV.
Health Lab
Study finds liver damage more commonly due to malignant tumors than cancer immunotherapy drug.
Health Lab
U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.